HOLOGIC INC (HOLX)

US4364401012 - Common Stock

77.15  +0.66 (+0.86%)

Fundamental Rating

6

Overall HOLX gets a fundamental rating of 6 out of 10. We evaluated HOLX against 187 industry peers in the Health Care Equipment & Supplies industry. HOLX scores excellent points on both the profitability and health parts. This is a solid base for a good stock. HOLX is valued correctly, but it does not seem to be growing.



8

1. Profitability

1.1 Basic Checks

HOLX had positive earnings in the past year.
In the past year HOLX had a positive cash flow from operations.
HOLX had positive earnings in 4 of the past 5 years.
HOLX had a positive operating cash flow in each of the past 5 years.

1.2 Ratios

Looking at the Return On Assets, with a value of 5.35%, HOLX belongs to the top of the industry, outperforming 84.49% of the companies in the same industry.
With an excellent Return On Equity value of 9.63%, HOLX belongs to the best of the industry, outperforming 85.56% of the companies in the same industry.
HOLX's Return On Invested Capital of 8.53% is amongst the best of the industry. HOLX outperforms 87.70% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for HOLX is significantly above the industry average of 8.53%.
The 3 year average ROIC (16.15%) for HOLX is well above the current ROIC(8.53%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 5.35%
ROE 9.63%
ROIC 8.53%
ROA(3y)13.44%
ROA(5y)10.53%
ROE(3y)26.72%
ROE(5y)22.35%
ROIC(3y)16.15%
ROIC(5y)14.15%

1.3 Margins

HOLX has a Profit Margin of 11.78%. This is amongst the best in the industry. HOLX outperforms 88.24% of its industry peers.
In the last couple of years the Profit Margin of HOLX has declined.
With an excellent Operating Margin value of 22.37%, HOLX belongs to the best of the industry, outperforming 95.19% of the companies in the same industry.
In the last couple of years the Operating Margin of HOLX has grown nicely.
HOLX has a Gross Margin of 55.12%. This is comparable to the rest of the industry: HOLX outperforms 48.66% of its industry peers.
HOLX's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 22.37%
PM (TTM) 11.78%
GM 55.12%
OM growth 3Y-8.49%
OM growth 5Y8.14%
PM growth 3Y-27.37%
PM growth 5YN/A
GM growth 3Y-2.18%
GM growth 5Y1.16%

7

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so HOLX is still creating some value.
Compared to 1 year ago, HOLX has less shares outstanding
HOLX has less shares outstanding than it did 5 years ago.
HOLX has a better debt/assets ratio than last year.

2.2 Solvency

An Altman-Z score of 4.35 indicates that HOLX is not in any danger for bankruptcy at the moment.
With a decent Altman-Z score value of 4.35, HOLX is doing good in the industry, outperforming 72.19% of the companies in the same industry.
The Debt to FCF ratio of HOLX is 2.71, which is a good value as it means it would take HOLX, 2.71 years of fcf income to pay off all of its debts.
HOLX has a Debt to FCF ratio of 2.71. This is amongst the best in the industry. HOLX outperforms 86.63% of its industry peers.
HOLX has a Debt/Equity ratio of 0.52. This is a neutral value indicating HOLX is somewhat dependend on debt financing.
HOLX's Debt to Equity ratio of 0.52 is on the low side compared to the rest of the industry. HOLX is outperformed by 67.38% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.52
Debt/FCF 2.71
Altman-Z 4.35
ROIC/WACC0.94
WACC9.05%

2.3 Liquidity

A Current Ratio of 3.97 indicates that HOLX has no problem at all paying its short term obligations.
HOLX's Current ratio of 3.97 is in line compared to the rest of the industry. HOLX outperforms 58.29% of its industry peers.
HOLX has a Quick Ratio of 3.29. This indicates that HOLX is financially healthy and has no problem in meeting its short term obligations.
HOLX has a better Quick ratio (3.29) than 60.96% of its industry peers.
Industry RankSector Rank
Current Ratio 3.97
Quick Ratio 3.29

3

3. Growth

3.1 Past

HOLX shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -1.79%.
HOLX shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 12.01% yearly.
HOLX shows a decrease in Revenue. In the last year, the revenue decreased by -2.37%.
Measured over the past years, HOLX shows a small growth in Revenue. The Revenue has been growing by 4.61% on average per year.
EPS 1Y (TTM)-1.79%
EPS 3Y-0.42%
EPS 5Y12.01%
EPS Q2Q%-2.83%
Revenue 1Y (TTM)-2.37%
Revenue growth 3Y2.19%
Revenue growth 5Y4.61%
Sales Q2Q%-0.85%

3.2 Future

Based on estimates for the next years, HOLX will show a small growth in Earnings Per Share. The EPS will grow by 7.31% on average per year.
The Revenue is expected to grow by 4.64% on average over the next years.
EPS Next Y5.05%
EPS Next 2Y7.12%
EPS Next 3Y8.02%
EPS Next 5Y7.31%
Revenue Next Year0.24%
Revenue Next 2Y2.82%
Revenue Next 3Y3.79%
Revenue Next 5Y4.64%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.

6

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 20.14 indicates a rather expensive valuation of HOLX.
85.56% of the companies in the same industry are more expensive than HOLX, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 28.91. HOLX is valued slightly cheaper when compared to this.
A Price/Forward Earnings ratio of 17.02 indicates a rather expensive valuation of HOLX.
86.63% of the companies in the same industry are more expensive than HOLX, based on the Price/Forward Earnings ratio.
HOLX's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 20.49.
Industry RankSector Rank
PE 20.14
Fwd PE 17.02

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of HOLX indicates a rather cheap valuation: HOLX is cheaper than 87.17% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, HOLX is valued cheaply inside the industry as 91.44% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 18.97
EV/EBITDA 15.14

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates HOLX does not grow enough to justify the current Price/Earnings ratio.
The excellent profitability rating of HOLX may justify a higher PE ratio.
PEG (NY)3.99
PEG (5Y)1.68
EPS Next 2Y7.12%
EPS Next 3Y8.02%

0

5. Dividend

5.1 Amount

No dividends for HOLX!.
Industry RankSector Rank
Dividend Yield N/A

HOLOGIC INC

NASDAQ:HOLX (7/12/2024, 10:10:59 AM)

77.15

+0.66 (+0.86%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap18.01B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 20.14
Fwd PE 17.02
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)3.99
PEG (5Y)1.68
Profitability
Industry RankSector Rank
ROA 5.35%
ROE 9.63%
ROCE
ROIC
ROICexc
ROICexgc
OM 22.37%
PM (TTM) 11.78%
GM 55.12%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.45
Health
Industry RankSector Rank
Debt/Equity 0.52
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 3.97
Quick Ratio 3.29
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)-1.79%
EPS 3Y-0.42%
EPS 5Y
EPS Q2Q%
EPS Next Y5.05%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-2.37%
Revenue growth 3Y2.19%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y